We identified nine single-nucleotide polymorphisms (SNPs) in the human integrin 4 (ITGB4) gene (17q24-q25), which encodes a cell-surface receptor, by screening all exons and exon-intron boundaries. Seven of these SNPs were present in coding regions and two in intronic sequences; four of the coding SNPs involved amino-acid substitutions. As the gene is implicated in the tumorigenesis of breast cancers, the polymorphic sites will serve as useful markers not only for distinguishing alleles in loss of heterozygosity (LOH) analyses but also for studying genetic susceptibility to malignancies in humans.
Introduction
Integrins comprise a large family of cell-surface receptors, each of them composed of two subunits, α and . Integrin 4 (ITGB4) interacts with α6; the α6/ 4 heterodimer binds to laminin and is involved in the formation and maintenance of hemidesmosomes. Germline mutations of the ITGB4 gene have been identified in patients with epidermolysis bullosa, an autosomal recessive genodermatosis (Vidal et al. 1995) . Natali et al. (1992) have documented underexpression of the ITGB4 gene in primary and metastatic breast cancers, suggesting that alteration of this gene contributes to carcinogenesis and/or metastasis in that disease. By screening its entire coding region for sequence variations, using polymerase chain reaction/single-strand conformation polymorphism analysis (PCR-SSCP), we identified nine single-nucleotide polymorphisms (SNPs) in the ITGB4 gene in a Japanese population sample.
Subjects and methods
DNA samples. Informed consent, in the formal style of the hospital, was obtained from 48 healthy Japanese volunteers. Genomic DNA was prepared from each blood sample according to the standard protocols.
PCR conditions. Each PCR was performed in a volume of 30µl, containing 100 ng genomic DNA, 10mM Tris-HCl (pH 8.3), 50mM KCl, 1.5 mM MgCl2, 0.01% gelatin, 200 µM of each dNTP, 10 pmol of each primer, and 0.1 unit of Taq polymerase, as described previously (Tsukamoto et al. 1998) . We used 54 primer sets to screen the entire coding sequence of the ITGB4 gene (exons 2-41). The primer sets for the eight regions found to contain SNPs are shown in Table 1 (two variant sites were found in intron 25). Cycling conditions were: 94°C for 3.5min, then 30 cycles of 94°C for 1min, 55°C-68°C for 1 min, and 72°C for 1 min, with final extension for 5min at 72°C, in a Gene Amp PCR 9600 System (Perkin Elmer Cetus, Norwalk, CT, USA). Annealing temperatures were adjusted according to the melting temperature of each pair of primers.
SSCP analysis.
A 10 ng aliquot of each PCR product was heat-denatured in the presence of 50% formamide, and electrophoresed for 11h at 10 V/cm and room temperature in an 8% polyacrylamide gel, with and without 10% glycerol in 0.5 ϫ TBE (1 ϫ TBE; 89mM Tris-borate, 89 mM boric acid, 2 mM EDTA; pH 8.0) (Harada et al. 1992) . DNA fragments were detected with a PlusOne DNA silverstaining kit (Amersham Pharmacia Biotech, Uppsala, Sweden), used according to the manufacturer's instructions.
DNA sequencing. Variant bands were used directly as templates for further amplification. The DNA sequence of each PCR product was determined using an Applied Biosystems model 377 DNA sequencer (Perkin Elmer Cetus).
Results and discussion
A total of healty 48 Japanese individuals were genotyped for sequence variations that might be present in any exon or exon-intron boundary of the ITGB4 gene. We identified nine SNPs, of which seven were located in coding regions and two in intronic sequences. Four of the coding SNPs reflected amino-acid substitutions. Genotypes and allele frequencies are summarized in Table 2 .
The human ITGB4 gene was originally mapped to chromosome 17q11-qter by analysis of human-rodent somatic cell hybrids (Hogervorst et al. 1991 ), but integrated mapping information in Genemap99 now locates this gene at 17q24-25. Human cancers derived from breast, esophagus, or ovary frequently show allelic losses on chromosome band 17q25. Moreover, a locus responsible for hereditary focal non-epidermolytic palmoplantar keratoderma (TOC), a condition associated with esophageal cancer, has been mapped to the same band. We ourselves have described frequent allelic losses and a common region of deletion at this chromosomal region in breast cancers (Fukino et al. 1999) .
The cytoplasmic domain of ITGB4 activates the p21 pathway of growth arrest and apoptosis (Clarke et al. 1995) . As the expression of ITGB4 is reduced in primary and metastatic breast cancer, the combined data suggest that the ITGB4 gene is a candidate for involvement in the allelic losses that occur on 17q in some tumors. The polymorphisms documented here will be useful not only for examining loss of heterozygosity (LOH) in the chromosomal regions where the ITGB4 gene is located (17q24-25) but also for studying associations between specific SNPs and cancer susceptibility. 
